Donepezil and Diabetes mellitus inadequate control - a phase IV clinical study of FDA data

Summary:

We study 22,455 people who have side effects when taking Donepezil. Diabetes mellitus inadequate control is found, especially among people who are female, 60+ old, have been taking the drug for 1 - 6 months, also take Alprazolam and have Type 2 diabetes.

The phase IV clinical study analyzes which people take Donepezil and have Diabetes mellitus inadequate control. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2023

22,455 people reported to have side effects when taking Donepezil.
Among them, 34 people (0.15%) have Diabetes mellitus inadequate control.

What is Donepezil?

Donepezil has active ingredients of donepezil hydrochloride. It is used in dementia. Currently, eHealthMe is studying from 22,741 Donepezil users.

What is Diabetes mellitus inadequate control?

Diabetes mellitus inadequate control is found to be associated with 1,800 drugs and 1,174 conditions by eHealthMe. Currently, we are studying 24,252 people who have Diabetes mellitus inadequate control.

Number of Donepezil and Diabetes mellitus inadequate control reports submitted per year:

Could Donepezil cause Diabetes mellitus inadequate control?

Time on Donepezil when people have Diabetes mellitus inadequate control *:

Gender of people who have Diabetes mellitus inadequate control when taking Donepezil *:

female: 87.88 %
male: 12.12 %

Age of people who have Diabetes mellitus inadequate control when taking Donepezil *:

Common drugs people take besides Donepezil *:

Common side effects people have besides Diabetes mellitus inadequate control *:

Fall: 22 people, 64.71%
Abdominal Pain Upper: 20 people, 58.82%
Mobility Decreased (ability to move is reduced): 20 people, 58.82%
Hypotension (abnormally low blood pressure): 20 people, 58.82%
Nausea (feeling of having an urge to vomit): 20 people, 58.82%
Constipation: 20 people, 58.82%
Parkinson's Disease: 20 people, 58.82%
Depression: 20 people, 58.82%
Dizziness: 20 people, 58.82%
Joint Pain: 20 people, 58.82%

Common conditions people have *:

Type 2 Diabetes: 22 people, 64.71%
High Blood Pressure: 19 people, 55.88%
Cardiac Failure: 19 people, 55.88%
Depression: 19 people, 55.88%
Pain: 18 people, 52.94%
Constipation: 16 people, 47.06%
Dizziness: 5 people, 14.71%
Hyperglycemia (high blood sugar): 5 people, 14.71%
Nasopharyngitis (inflammation of the nasopharynx): 5 people, 14.71%
Abdominal Pain Upper: 5 people, 14.71%

* Approximation only. Some reports may have incomplete information.

Do you take Donepezil and have Diabetes mellitus inadequate control?

Check whether Diabetes mellitus inadequate control is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Donepezil side effects by duration, gender and age:

Donepezil side effects (22,741 reports)

Diabetes mellitus inadequate control treatments and more:

Diabetes mellitus inadequate control (24,252 reports)

Common drugs associated with Diabetes mellitus inadequate control:

All the drugs that are associated with Diabetes mellitus inadequate control:

Diabetes mellitus inadequate control (1,800 drugs)

Common conditions associated with Diabetes mellitus inadequate control:

Type 2 diabetes: 4,254 reports
Diabetes: 3,994 reports
High blood pressure: 1,524 reports
Type 1 diabetes: 981 reports
Depression: 950 reports

All the conditions that are associated with Diabetes mellitus inadequate control:

Diabetes mellitus inadequate control (1,174 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on donepezil hydrochloride (the active ingredients of Donepezil) and Donepezil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.